NCT00006015: Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer |
|
|
| Terminated | 2 | 26 | US | trastuzumab, Herceptin, fluorouracil, 5-FU, leucovorin calcium, oxaliplatin | National Cancer Institute (NCI) | Colorectal Cancer | 12/02 | 02/03 | | |
NCT00003995: Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2 |
|
|
| Completed | 2 | 32 | US | trastuzumab, irinotecan hydrochloride | National Cancer Institute (NCI) | Colorectal Cancer | 03/06 | | | |
